Connolly, E M <br/><br/>
Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.  [electronic resource] 

 -  British journal of cancer  Jul 2002 
 - 231-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6600462  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood supply<br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Apoptosis--drug effects<br/>Cyclooxygenase 1<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--pharmacology<br/>Drug Screening Assays, Antitumor<br/>Endothelial Growth Factors--biosynthesis<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Indomethacin--pharmacology<br/>Isoenzymes--antagonists & inhibitors<br/>Lung Neoplasms--drug therapy<br/>Lymphokines--biosynthesis<br/>Mammary Neoplasms, Experimental--blood supply<br/>Membrane Proteins<br/>Mice<br/>Mice, Inbred BALB C<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Neoplasm Transplantation<br/>Neovascularization, Pathologic--drug therapy<br/>Prostaglandin-Endoperoxide Synthases<br/>Pyrazoles--pharmacology<br/>Random Allocation<br/>Substrate Specificity<br/>Sulfonamides--pharmacology<br/>Tumor Cells, Cultured--enzymology<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors